NASDAQ:MGTX

MeiraGTx up 5% after CEO sale filing

MeiraGTx up 5% after CEO sale filing

MeiraGTx shares rose 5.3% to $9.61 Wednesday after an SEC filing showed CEO Alexandria Forbes sold 62,000 shares under a pre-arranged plan, retaining 1.39 million. The company, now valued at $781 million, recently regained rights to bota-vec from Johnson & Johnson and received FDA Breakthrough Therapy Designation for AAV2-hAQP1. MeiraGTx reported no product revenue and a $46.3 million quarterly net loss.
May 20, 2026

Stock Market Today

  • CBA vs Macquarie: Key ASX Financial Battle Draws Investor Interest
    May 29, 2026, 10:00 PM EDT. Investors are closely watching the financial showdown between Commonwealth Bank of Australia (CBA) and Macquarie Group on the ASX. Both are influential players in Australia's financial sector. This rivalry highlights competitive dynamics within banking and financial services stocks on the Australian Securities Exchange (ASX). The performance and strategies of these companies are pivotal for market watchers assessing sector trends and potential shifts. Understanding this competition is critical for investors monitoring the Australian financial stock landscape and sector-specific developments impacting the broader market.